British American Tobacco (LSE:BATS) Stock After 43% Year Gain And DCF Valuation Gap

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.

If you are trying to figure out whether British American Tobacco is attractively priced or already fully valued, the current share price alone is only part of the story. The stock last closed at £46.77, with reported returns of 2.0% over 7 days, 1.9% over 30 days, 11.6% year to date and 43.0% over 1 year. These figures provide useful context before comparing that price to underlying value. Recent coverage around British American Tobacco has focused on its position within the global tobacco sector and ongoing scrutiny of the industry. This can influence how investors think about future regulatory and competitive risks. This backdrop helps frame how the market is currently pricing the stock and why sentiment can shift quickly around any new developments. On Simply Wall St's valuation checks, British American Tobacco currently records a valuation score of 4 out of 6. The rest of this article will walk through what that means using several valuation methods before ending with a broader way to think about the stock's value in your portfolio.

British American Tobacco delivered 43.0% returns over the last year. See how this stacks up to the rest of the Tobacco industry.

Approach 1: British American Tobacco Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model estimates what British American Tobacco is worth today by taking projected future cash flows and discounting them back to a present value. It is essentially asking what those future pounds of cash are worth in your hand right now.

On this model, British American Tobacco is assessed using a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is reported at about £5.75b. Analyst projections and subsequent extrapolations by Simply Wall St point to free cash flow of £8.43b by 2030, with a series of yearly projections between now and then that are discounted back to today using the model's assumptions.

Adding those discounted cash flows together gives an estimated intrinsic value of £63.80 per share. Compared with the recent share price of £46.77, the DCF output suggests the stock trades at a 26.7% discount, which indicates British American Tobacco shares are currently assessed as undervalued on this method.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests British American Tobacco is undervalued by 26.7%. Track this in your watchlist or portfolio, or discover 7 more high quality undervalued stocks.

Story Continues

BATS Discounted Cash Flow as at Jul 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for British American Tobacco.

Approach 2: British American Tobacco Price vs Earnings

For a profitable company like British American Tobacco, the P/E ratio is a useful shorthand for what investors are currently willing to pay for each pound of earnings. It links the share price directly to the earnings power of the business, which tends to be a core driver of long term returns.

What counts as a normal or fair P/E often reflects how the market views a company's growth prospects and risk profile. Higher expected growth or lower perceived risk can support a higher multiple, while slower expected growth or higher risk usually points to a lower one.

British American Tobacco currently trades on a P/E of 13.16x. This sits above the Tobacco industry average of 12.22x, yet below the peer group average of 17.01x. Simply Wall St's Fair Ratio for British American Tobacco is 20.86x, which is a proprietary estimate of what the P/E could be given factors such as earnings growth, industry, profit margin, market cap and company specific risks. Because it adjusts for these fundamentals, the Fair Ratio can provide a more tailored benchmark than a simple comparison with peers or the broader industry. On this measure, the current P/E of 13.16x is below the Fair Ratio of 20.86x.

Result: UNDERVALUEDLSE:BATS P/E Ratio as at Jul 2026

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 9 top founder-led companies.

Upgrade Your Decision Making: Choose your British American Tobacco Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St give you a clear story for British American Tobacco that ties your view of its future revenue, earnings and margins to a financial forecast, a Fair Value, and a simple comparison with today's share price.

Think of a Narrative as your own explanation for what is driving British American Tobacco, written in plain language but backed by numbers, so you can see how your expectations feed into a Fair Value that helps you decide whether the stock currently looks expensive or cheap against that story.

On the Simply Wall St Community page, Narratives are designed to be easy to use and are updated as new information appears, such as news or earnings. This means your Fair Value estimate for British American Tobacco can evolve rather than staying fixed to an outdated thesis.

For example, one bullish British American Tobacco Narrative on the platform currently anchors on a Fair Value of £57.50, while a more cautious Narrative points to £39.07. That range reflects how different investors can look at the same company and reach very different conclusions about what it is worth today.

For British American Tobacco, however, we will make it really easy for you with previews of two leading British American Tobacco Narratives:

🐂 British American Tobacco Bull Case

Fair value in this bullish Narrative is set at £50.27 per share.

At the last close of £46.77 this implies British American Tobacco trades at about a 7.0% discount to that fair value estimate.

Revenue growth in this scenario is set at 3.24% a year.

Emphasis on reduced risk products and emerging markets, with Modern Oral and Heated products expected to support more diversified revenue and margins over time. Focus on digital transformation and cost programs such as Fit2Win to support cash generation, capital allocation and debt reduction while funding growth. Analysts using this view see British American Tobacco as roughly fairly priced against their £50.27 target, with the key swing factors being regulation, illicit trade and the pace of the smokeless transition.

🐻 British American Tobacco Bear Case

Fair value in this more cautious Narrative is set at £39.07 per share.

At the last close of £46.77 this implies British American Tobacco trades about 19.7% above that fair value estimate.

Revenue growth in this scenario is set at 3.16% a year.

Highlights pressure from regulation, changing consumer attitudes and ESG driven selling, which together could weigh on British American Tobacco's long run margins and valuation. Points to dependence on combustible sales in emerging markets and exposure to currency, regulatory and illicit trade risks as reasons earnings could be more volatile. Assumes a fair value of £39.07 based on lower profit margins and a reduced future P/E, with progress on smokeless products and cost savings treated as partial offsets rather than full solutions.

Ultimately, British American Tobacco sits between these narratives. The key question for you is which set of assumptions feels closer to how you think the smokeless transition, regulation and cash returns will play out over time. See what the community is saying about British American Tobacco

Do you think there's more to the story for British American Tobacco? Head over to our Community to see what others are saying!LSE:BATS 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include BATS.L.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments